Method for establishing, restoring, and preserving homeostasis of the ocular surface
AssigneeI.Com Medical GmbH
InventorsWOLFGANG GEORG KONRAD MÜLLER-LIERHEIM, GYSBERT-BOTHO VAN SETTEN
Life of this patent
Estimating the term…
Abstract
The invention concerns a method for reducing or delaying the onset of irritation, discomfort, inflammation (acute or chronic), and/or an immune response at the ocular surface by topically administering a fluid comprising high molecular weight hyaluronic acid to the ocular surface of the eye of a human or non-human animal subject, wherein the hyaluronic acid has an intrinsic viscosity of >2.5 m3/hg and a concentration of <0.2% w/v.
Claims21
1-95. (canceled)
A method for treating severe dry eye, comprising topically administering a fluid to the ocular surface of the eye of a human or non-human animal subject with severe dry eye, wherein the fluid comprises high molecular weight hyaluronic acid having an intrinsic viscosity of >2.5 m3/kg and a concentration of <0.2% w/v.
Dependencies are inferred from the claim text.